Phibro Animal Health Corporation (NASDAQ: PAHC) is a Healthcare company (Drug Manufacturers - Specialty & Generic) with a market capitalization of $1.4B. The Maz Rating grades it against the other companies in its sector.
Phibro Animal Health Corporation's current Maz Rating and its five factor grades are for members: log in to see them.
At $34.92, Phibro Animal Health Corporation trades at 13.7x trailing earnings, 0.9x sales and 3.4x book value, with an EV/EBITDA of 9.0. Over the last twelve months it generated about $1.5B of revenue and $104M of net income. It runs a gross margin of 33.8%, an operating margin of 13.0% and a net margin of 6.7%. It shows return on equity of 27.4%, return on invested capital of 11.7% and a free cash flow yield of 1.5%. On the balance sheet: a debt-to-equity ratio of 1.89 and a current ratio of 3.20. Over the past 52 weeks the share price ranged from $28.25 to $60.08, with a beta of 0.42.
Phibro Animal Health Corporation pays a dividend yielding 1.38%, with 19% of earnings paid out. Its Maz Dividend Score is 1.57 out of 5, ranked against the other dividend payers in its sector (Safety 2.37, Growth 1.43, Yield 3.70, Consistency 2.12).
14 Wall Street analyst ratings cover the stock: 6 Buy, 4 Hold and 4 Sell, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.